Koshiyama H, Kato Y, Shimatsu A, Murakami Y, Hattori N, Ishikawa Y, Imura H
Department of Internal Medicine, Kyoto University Faculty of Medicine, Japan.
Proc Soc Exp Biol Med. 1989 Nov;192(2):105-8. doi: 10.3181/00379727-192-42962.
Noradrenergic mechanisms have a stimulatory role in regulating prolactin (PRL) secretion in the rat. We investigated the mechanism by which the alpha 2-adrenergic system stimulates PRL release in urethane-anesthetized male rats. Intracerebroventricular injection of norepinephrine (2 micrograms/rat) or epinephrine (100 ng and 1 microgram/rat) caused an increase in plasma PRL levels. The PRL increase induced by epinephrine was much greater than that by norepinephrine. Intracerebroventricular injection of phentolamine (1 microgram/rat), an alpha-antagonist, blunted the plasma PRL increase induced by epinephrine (100 ng intracerebroventricularly). Plasma PRL levels were increased by intravenous injection of alpha 2-agonists, clonidine (15 micrograms/100 g of body wt), and xylazine (200 micrograms/100 g of body wt). Plasma PRL increase induced by clonidine or xylazine was suppressed by intravenous injection of naloxone (125 micrograms/100 g of body wt), an opiate antagonist. These findings suggest that alpha 2-adrenergic mechanisms stimulate pituitary PRL secretion, at least partly, by activating endogenous opioid peptides in the rat.
去甲肾上腺素能机制在调节大鼠催乳素(PRL)分泌中起刺激作用。我们研究了α2-肾上腺素能系统在氨基甲酸乙酯麻醉的雄性大鼠中刺激PRL释放的机制。脑室内注射去甲肾上腺素(2微克/只大鼠)或肾上腺素(100纳克和1微克/只大鼠)导致血浆PRL水平升高。肾上腺素诱导的PRL升高远大于去甲肾上腺素诱导的升高。脑室内注射酚妥拉明(1微克/只大鼠),一种α拮抗剂,可减弱由肾上腺素(脑室内注射100纳克)诱导的血浆PRL升高。静脉注射α2-激动剂可乐定(15微克/100克体重)和赛拉嗪(200微克/100克体重)可使血浆PRL水平升高。可乐定或赛拉嗪诱导的血浆PRL升高被静脉注射纳洛酮(125微克/100克体重),一种阿片拮抗剂所抑制。这些发现表明,α2-肾上腺素能机制至少部分地通过激活大鼠体内的内源性阿片肽来刺激垂体PRL分泌。